Comprehensive testing, simplified

Mayo Clinic Laboratories’ comprehensive fluorescence in situ hybridization (FISH) panels simplify the ordering process to ensure every patient receives the right test. Our diagnostic panels were designed to align with testing requirements of the National Comprehensive Cancer Network (NCCN) and the CLL-International Prognostic Index (CLL-IPI). 

The inclusion of the most relevant genetic probes into our adult, pediatric, and monitoring FISH panels enables detailed insights on diagnosis, prognosis, and treatment options, equipping providers and patients with confidence that nothing related to the disease state was missed. Our streamlined panels save time and expense incurred through sequential test ordering by providing precision insights at the beginning of a patient’s medical journey, ensuring they are on the best path forward.

Key testing

AMLAF | Adult AML FISH Panel

• Performed on specimens from patients ages 31 and older with acute myeloid leukemia (AML)

AMLPF | Pediatric FISH Panel

• Performed on specimens from patients ages 30 and younger with AML

AMLMF | Specified FISH Panel

• Probe sets to be performed must be specified upon ordering. Any probe set(s) captured in AMLAF or AMLPF can be ordered under AMLMF

CILDF | Congenital Infantile Leukemia, Diagnostic FISH Panel

• Performed on specimens from patients 18 months and younger

CILPF | Congenital Infantile Leukemia, FISH, Tissue

• Performed on specimens from patients 18 months and younger

CILMF | Congenital Infantile Leukemia, Specified FISH Panel

• Probe set(s) to be performed must be specified upon ordering. Any probe set(s) captured under CILDF can be ordered